Local vaginal estrogen is one of the most effective treatments in menopause care and one of the most often abandoned — usually for practical reasons nobody warned about. Women stop because it is messy, because they were not told how long it takes, or because they read the packet insert and were frightened by a warning written for a different medicine.

Where we stand: Menova is an independent publication. We sell no hormones, we are not your doctor, and this is general education, not medical advice. Follow the instructions for your specific product — brands and schedules differ.

What it treats

The tissue changes of menopause — dryness, thinning, fragility, itching, discomfort during sex, urinary urgency and frequency, and recurrent urinary infections. Collectively called genitourinary syndrome of menopause.

The important distinction from hot flashes: this does not resolve on its own. Hot flashes eventually stop for most women. Genitourinary symptoms progress if untreated. That is why treating early matters — see GSM and urinary changes.

It is a local treatment. Very little reaches the bloodstream, and it is a different proposition from systemic hormone therapy — including for many women who cannot take systemic hormones. Our discussion of safety is in is vaginal estrogen safe.

The forms

Cream. Applied with an applicator, or with a finger for external symptoms. Flexible — you can put it exactly where the discomfort is, including the vulva and around the urethra, which the other forms cannot do. Messiest.

Pessary or tablet. A small tablet inserted with an applicator. Much less mess. Treats the vagina rather than the vulva.

Ring. Left in place and changed every three months. The most convenient by a wide margin, and worth asking about if you keep forgetting. You can usually leave it in for sex; it can be removed and replaced if you prefer.

Gel. Available in some countries.

All are effective. The choice is largely about what you will actually keep using — which is the real determinant of whether treatment works.

The schedule

Most products follow the same pattern:

  • Loading phase: daily, or most nights, for about two weeks
  • Maintenance: twice a week, ongoing

Two things follow that women are frequently not told:

It is ongoing, not a course. Symptoms return within a few months of stopping, because the underlying change is still there. This is a long-term treatment, more like a moisturiser than an antibiotic.

Do not stop when you feel better. That is the treatment working, not the treatment finishing.

Practical points nobody mentions

  • Use it at night. Gravity works against you standing up, and lying down for several hours means more stays where it is meant to be
  • Expect some discharge in the morning. Normal, not a sign of infection. A panty liner solves it
  • Wash the applicator with warm water and let it dry
  • Cream can be applied externally too — with a clean finger to the vulva and around the urethral opening, which is where a lot of the discomfort and urinary symptoms actually come from. Many women use only the applicator and never treat the area that hurts most
  • Skipping a dose is not a problem. Take the next one as scheduled; do not double up
  • Set a recurring reminder for your two maintenance nights
  • Wash your hands afterwards, and note that estrogen cream can transfer to a partner through skin or oral contact — apply after sex rather than before

How long before it works

This is where most abandonment happens.

  • Some improvement in dryness: two to three weeks
  • Meaningful change: about three months
  • Urinary symptoms and recurrent UTIs: often longer, sometimes six months

Judge it at three months, not three weeks. Give it the loading phase and a full maintenance period before deciding.

If there is genuinely no change at three months, that is worth reporting rather than stopping silently — the form, dose, or the diagnosis may need revisiting.

The packet insert

You will open the box and find a warning about endometrial cancer, breast cancer, stroke and dementia.

Worth knowing where that comes from: in several countries the labelling for low-dose vaginal estrogen carries a class warning derived from studies of systemic hormone therapy, at much higher doses. Menopause specialist bodies have argued for years that this warning is not appropriate for low-dose local products and that it deters women from an effective treatment.

We are not telling you to disregard a label. We are telling you the question to ask: "Does this warning apply to low-dose local vaginal estrogen, or is it carried over from systemic therapy?" Your prescriber can answer it — and most will tell you the risk profile of the local product is very different. See is vaginal estrogen safe.

Do you need a progestogen with it?

Generally no, for standard low-dose local vaginal estrogen — the systemic absorption is too low to require endometrial protection. This differs from systemic estrogen, where a progestogen is essential if you have a uterus.

Do not extrapolate in either direction. If you are on systemic HRT as well, the progestogen for that is still required — see progesterone in menopause.

Any unexpected bleeding still needs reporting, whatever you are on — see bleeding after menopause.

Using it alongside other things

  • With systemic HRT. Common and often necessary. Systemic therapy does not always resolve genitourinary symptoms, and adding local treatment is standard rather than excessive
  • With moisturisers and lubricants. These are complementary, not alternatives — the estrogen treats the tissue, the lubricant handles friction at the time; see moisturiser versus lubricant
  • For recurrent UTIs. Vaginal estrogen has evidence for reducing recurrence after menopause and is recommended in guidance — an option many women are never offered before repeated antibiotics; see recurrent UTIs after menopause
  • Before pelvic floor physiotherapy, where healthier tissue makes the work more tolerable; see leaking when you exercise

After breast cancer

A more complex conversation rather than an automatic no. Vaginal estrogen is used in some women after breast cancer, and the decision depends on the type of cancer and the treatment — particularly whether you are on an aromatase inhibitor.

Non-hormonal options should be tried first, and this decision belongs with your oncology team rather than being made alone in either direction. See menopause after breast cancer.

When to go back

  • No improvement after three months
  • Any bleeding
  • New pain, or pain that is worse rather than better
  • Persistent vulval itching, splitting, or a white or changed patch of skin — this needs examination rather than more treatment, because conditions such as lichen sclerosus need their own diagnosis
  • A lump or ulcer
  • Symptoms that return after a period of improvement

What to ask for

"I have vaginal dryness and urinary symptoms. Could we discuss local vaginal estrogen? I'd like to understand which form would suit me, whether I should use the cream externally as well, and how long before I judge it."

Our free printable visit prep sheet gives you a page to hand over if saying it out loud is the hard part — and this is one of the most under-reported symptoms in menopause care, so that matters.

The free 2-minute Menova self-check organizes your wider symptom picture — no account, not a diagnosis, and your answers never leave your device.

This article is general education, not medical advice. Follow the instructions for your prescribed product. Report any bleeding, new pain, or persistent vulval skin changes to a licensed clinician.

Sources: The Menopause Society, ACOG — Vaginal Dryness, NICE NG23 — Menopause, and NHS — Vaginal Dryness.